0001630575-20-000003.txt : 20201223 0001630575-20-000003.hdr.sgml : 20201223 20201222181736 ACCESSION NUMBER: 0001630575-20-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201223 DATE AS OF CHANGE: 20201222 EFFECTIVENESS DATE: 20201223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vivace Therapeutics, Inc. CENTRAL INDEX KEY: 0001630575 IRS NUMBER: 320452793 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-384119 FILM NUMBER: 201409285 BUSINESS ADDRESS: STREET 1: 2929 CAMPUS DRIVE STREET 2: SUITE 405 CITY: SAN MATEO STATE: CA ZIP: 94403 BUSINESS PHONE: 858-344-7499 MAIL ADDRESS: STREET 1: 2929 CAMPUS DRIVE STREET 2: SUITE 405 CITY: SAN MATEO STATE: CA ZIP: 94403 D 1 primary_doc.xml X0708 D LIVE 0001630575 Vivace Therapeutics, Inc. 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 858-344-7499 DELAWARE None None Corporation true Shuang Qiao 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 Executive Officer Director Edward Hu 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 Director Leonard Post 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 Director Tim Shannon 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 Director Jun Wu 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 Director Chenguang Zhou 2929 Campus Drive, Suite 150 San Mateo CA CALIFORNIA 94403 Director Biotechnology Decline to Disclose 06b false 2020-12-11 false true false 0 29999993 29999993 0 false 6 0 0 0 false Vivace Therapeutics, Inc. /s/ Shuang Qiao Shuang Qiao President & CEO 2020-12-22